Why Lucence exists
Lucence provides a liquid biopsy test that analyzes both ctDNA and ctRNA, improving detection of fusions. It gathers biomarkers from blood and other bodily fluids that can guide treatment and monitor disease progression, including minimum residual disease monitoring and early detection. Patients get a fuller biomarker picture from a fluid-based test.
Prefer the source? Lucence (ctDNA + ctRNA test, improves detection of fusions)'s own site has more.
